Tuesday’s Highlights at Noon: Arrowhead Research (ARWR), Glu Mobile (GLUU), Xoma (XOMA)

So far Tuesday, December 3, NASDAQ is up 0.49% and the S&P is down -0.42%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Arrowhead Research (ARWRResearch Report), Glu Mobile (GLUUResearch Report) and Xoma (XOMAResearch Report).

Arrowhead Research is up 14.31% in midday trading to $70.87. Shares opened today at $62.00. The company has a 52-week low of $10.41 and a 52-week high of $73.72. On the Street’s front, the average 12-month analyst price target for the stock is $67.60, marking a 9.03% potential upside from current levels. In a report issued on November 29, Chardan analyst Keay Nakae reiterated a Buy rating on ARWR, with a price target of $81.00, which implies an upside of 31% from current levels. Separately, on November 19, Cantor Fitzgerald’s Elemer Piros maintained a Hold rating on the stock and has a price target of $50.00. In the last 30 days, insiders purchased $65.65K worth of ARWR shares. Over the last 3 months, the insider sentiment on Arrowhead Research has been negative based on 43 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Glu Mobile is up 4.78% in midday trading to $5.59. Shares opened today at $5.33. The company has a 52-week low of $4.11 and a 52-week high of $11.75. On the Street’s front, the average 12-month analyst price target for the stock is $7.29, marking a 36.77% potential upside from current levels. In a report issued on November 19, Roth Capital analyst Darren Aftahi maintained a Buy rating on GLUU, with a price target of $6.00, which implies an upside of 13% from current levels. In the last 30 days, insiders have sold $195.7K worth of GLUU shares. Over the last 3 months, the insider sentiment on Glu Mobile has been negative based on 38 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Xoma is up 4.09% in midday trading to $24.45. Shares opened today at $23.49. The company has a 52-week low of $11.02 and a 52-week high of $26.90. On the Street’s front, the average 12-month analyst price target for the stock is $27.50, marking a 17.07% potential upside from current levels. In a report issued on November 6, Wedbush analyst Liana Moussatos reiterated a Buy rating on XOMA, with a price target of $25.00, which represents a potential upside of 6% from where the stock is currently trading. Separately, on November 5, Cowen’s Phil Nadeau maintained a Hold rating on the stock .

See today’s analyst top recommended stocks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.